Benzinga | Jan 4, 2022 06:55AM EST

BTIG Initiates Coverage On Renalytix with Buy Rating, Announces Price Target of $24

BTIG analyst Mark Massaro initiates coverage on Renalytix (NASDAQ:RNLX) with a Buy rating and announces Price Target of $24.